Molybdenum Glycinate by Thorne Research 1mg 60 Capsules

Regular price $10.10 Sale

Molybdenum Glycinate by Thorne Research 1mg 60 Capsules

Molybdenum is a cofactor in three important enzymatic reactions – xanthine oxidase/dehydrogenase, aldehyde oxidase, and sulfite oxidase.* The first two enzymatic reactions play a role in the liver's detoxification of environmental toxins, certain drugs, estradiol, and progesterone.* Because molybdenum – as an essential cofactor for sulfite oxidase – enhances sulfite metabolism, supplementation with molybdenum glycinate benefits individuals who suffer sensitivity to sulfites used in meat, fish, salad bar items, and dehydrated fruits and vegetables.* Thorne's Molybdenum Glycinate is a highly absorbable form of molybdenum.*

Sulfite sensitivity can manifest in a number of ways, such as wheezing, chest tightness, coughing, shortness of breath, flushing, itching, hives, swelling of eyes, hands and feet, nausea, headache, and diarrhea. Sulfite oxidase, the most important molybdenum-dependent enzyme in humans, oxidizes sulfite to sulfate, the final step in the metabolism of sulfur-containing amino acids.

Suggested Use:

Take 1 capsule one to three times daily or as recommended by your health professional.

One Capsule Contains:
Molybdenum (as TRAACS® Molybdenum Glycinate Chelate)* 1 mg

Other Ingredients: Microcrystalline Cellulose, Hypromellose (derived from cellulose) capsule, Leucine.*This product uses Albion's TRAACS® Molybdenum Glycinate chelate. TRAACS is a registered trademark of Albion International, Inc.

ALLERGY WARNING
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.

PREGNANCY
If pregnant, consult your health professional before using this product.

INTERACTIONS
There are no known adverse interactions or contraindications at publication date.

*These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not meant to diagnose, treat, or cure any disease or medical condition.

Back to Thorne Research